Mycosis fungoides medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin®) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H), Vorinostat (Zolinza®), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil®), Gemcitabine (Gemzar®), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation. | Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin®) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H), Vorinostat (Zolinza®), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil®), Gemcitabine (Gemzar®), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation. | ||
more TSEB radiation in some cases | |||
radiation therapy to bulky tumours or lymph nodes | |||
PUVA | |||
topical or systemic chemotherapy | |||
biological therapy | |||
Read more: http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on#ixzz3xcr1oK2i | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ '''Medical therapy for cutaneous T cell lymphoma''' | |||
! style="background: #4479BA; color:#FFF;" | Stage | |||
! style="background: #4479BA; color:#FFF;" | PUVA | |||
! style="background: #4479BA; color:#FFF;" | Topical chemotherapy | |||
! style="background: #4479BA; color:#FFF;" | Systemic chemotherapy | |||
! style="background: #4479BA; color:#FFF;" | Radiotherapy | |||
! style="background: #4479BA; color:#FFF;" | Biological therapy | |||
! style="background: #4479BA; color:#FFF;" | Retinoid therapy | |||
! style="background: #4479BA; color:#FFF;" | Photopheresis | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with interferon alfa | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | To 1 or 2 skin lesions (local radiation therapy) or to all the skin on the body (TSEB) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with topical chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; text-align: center; background: #F5F5F5;" | --------- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with interferon alfa | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | To 1 or 2 skin lesions (local radiation therapy) or to all the skin on the body (TSEB) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with topical chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; text-align: center; background: #F5F5F5;" | --------- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage III | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with interferon alfa or systemic chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be combined with other skin-focussed therapies | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* To all the skin on the body (TSEB) | |||
* As palliative therapy to reduce the size of tumours or relieve symptoms | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with topical chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IV | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with interferon alfa or systemic chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* To all the skin on the body (TSEB) | |||
* As palliative therapy to reduce the size of tumours or relieve symptoms | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with topical chemotherapy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be given by itself or with TSEB | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Recurrent cutaneous T cell lymphoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* More TSEB radiation in some cases | |||
* Radiation therapy to bulky tumours or lymph nodes | |||
| style="padding: 5px 5px; background: #F5F5F5;" | May be offered | |||
| style="padding: 5px 5px; text-align: center; background: #F5F5F5;" | --------- | |||
| style="padding: 5px 5px; text-align: center; background: #F5F5F5;" | --------- | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 19:27, 18 January 2016
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical therapy
There is no cure for CTCL, but there are a variety of treatment options available and some CTCL patients are able to live somewhat normal lives with this cancer, although symptoms can be debilitating and painful, even in earlier stages.
Treatments include: Topical Corticosteroids, Bexarotene Gel, Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad & Narrow Band UVB or PUVA), Local & Total Skin Electron Beam Radiation, Conventional Radiation Therapy, Oral Corticosteroids, Bexarotene (Targretin®) Capsules, Photopheresis, Interferons, Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H), Vorinostat (Zolinza®), Methotrexate, Pentostatin & other purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal doxorubicin (Doxil®), Gemcitabine (Gemzar®), Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation.
more TSEB radiation in some cases radiation therapy to bulky tumours or lymph nodes PUVA topical or systemic chemotherapy biological therapy
Stage | PUVA | Topical chemotherapy | Systemic chemotherapy | Radiotherapy | Biological therapy | Retinoid therapy | Photopheresis |
---|---|---|---|---|---|---|---|
Stage I | May be given by itself or with interferon alfa | May be offered | May be offered | To 1 or 2 skin lesions (local radiation therapy) or to all the skin on the body (TSEB) | May be given by itself or with topical chemotherapy | May be offered | --------- |
Stage II | May be given by itself or with interferon alfa | May be offered | May be offered | To 1 or 2 skin lesions (local radiation therapy) or to all the skin on the body (TSEB) | May be given by itself or with topical chemotherapy | May be offered | --------- |
Stage III | May be given by itself or with interferon alfa or systemic chemotherapy | May be offered | May be combined with other skin-focussed therapies |
|
May be given by itself or with topical chemotherapy | May be offered | May be offered |
Stage IV | May be given by itself or with interferon alfa or systemic chemotherapy | May be offered | May be offered |
|
May be given by itself or with topical chemotherapy | May be offered | May be given by itself or with TSEB |
Recurrent cutaneous T cell lymphoma | May be offered | May be offered | May be offered |
|
May be offered | --------- | --------- |